The summary below is from the full report titled “High-Dose Chemotherapy and Syngeneic Hemopoietic Stem-Cell Transplantation for Severe, Seronegative Rheumatoid Arthritis.” It is in the 5 October 1999 issue of Annals of Internal Medicine (volume 131, pages 507-509). The authors are G. McColl, H. Kohsaka, J. Szer, and I. Wicks.
A Novel but Potentially Risky Therapy for Severe Rheumatoid Arthritis. Ann Intern Med. 1999;131:507. doi: https://doi.org/10.7326/0003-4819-131-7-199910050-00044
Download citation file:
Published: Ann Intern Med. 1999;131(7):507.
Rheumatoid Arthritis, Rheumatology.
Results provided by:
Copyright © 2020 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use